Inflammation is a normal body response to injury. However, inflammation also contributes to the progression of various diseases including cancer, atherosclerosis, asthma, obesity, and rheumatoid arthritis. Thus, the discovery of antiinflammatory agents remains chalenging. Medicinal plant is a potential source of drug discovery, including for antiinflammatory agents. One of the medicinal plants traditionally used for treating inflammatory diseases is Coleus atropurpureus. This study evaluated the in vivo anti-inflammatory effect of Coleus atropurpureus leaves extract and its fractions. Wistar rats were divided into 5 groups: negative control (solvent treatment), positive control (Diclofenac 9 mg/kg BW), ethanol extract (EE), nhexane fraction (HF), and ethanol-water fraction (EWF). The extract and fractions were given at the same dose (45 mg/kg BW) 6 h prior to the induction of inflammation using carrageenan. Thin layer chromatography (TLC) analysis was done to identify the chemical components of the extract and fractions. The ethanol extract (EE), n-hexane fraction (HF), and ethanol-water fraction (EWF) reduced paw oedema thickness by 23.66, 19.01, and 20.80%, respectively, compared to the negative control. TLC analysis revealed the difference in the phytochemical content of the fractions. The HF mainly contained terpenoids, whereas the EFW contained flavonoids. This study demonstrated that EE, HF, and EWF of C. atropurpureus leaves have antiinflammatory activity in carrageenan-induced paw edema in rats.